ARTICLE | Clinical News
Vfend voriconazole regulatory update
March 25, 2002 8:00 AM UTC
Europe granted marketing approval for PFE's oral and intravenous formulations of Vfend to treat life-threatening fungal infections. The product, a second generation triazole ergosterol synthesis inhi...